user avatar
Immunai
@Immunaitech
Decoding the Immune System to Improve Health
Joined May 2020
Posts
  • user avatar
    Join us next Wednesday for a symposium all about Gene Regulatory Networks. This fantastic panel moderated by Caroline Uhler is not to be missed. You can secure your spot here: tinyurl.com/yc65mu34
  • user avatar
    Excited to share that we’ve acquired @NewsFromNebion and brought on world-renowned #immunologist Jacques Banchereau as CSO, @mjacobstein as CBO, and #Moderna co-founder Robert Langer as a board member. Learn more from @AlexWestchester in @GENbio: tinyurl.com/u69hs23a
  • user avatar
    A better understanding of the #immunesystem is essential to avoiding another #pandemic. Learn more from our CEO and co-founder, @NoamSolomon1
    00:00
  • user avatar
    We’re excited to be included on @CBInsights 130+ AI startups reinventing healthcare in the drug R&D category! With AMICA, the largest immunological database of its kind, we are poised to answer some of the most pressing questions in immunology to advance drug discovery.
  • user avatar
    At Immunai, our goal is to decode the #immunesystem so we can better #detect, #diagnose, and treat #disease. Read about how we use #singlecellanalysis and #machinelearning to map immune cells in @TechCrunch:
  • user avatar
    Excited to announce that we’ve raised $60M to reprogram the #immunesystem. Read more about our news from @etherington in @TechCrunch here: tinyurl.com/cm0ptdu3 #ai #machinelearning #biotech #immunotherapy
  • user avatar
    For @GENbio’s March issue on immune profiling in #cancer, our CEO @NoamSolomon1, shared our vision for single-cell technology’s role in answering the biggest questions about the immune system. You can read the full article here: tinyurl.com/2sa2ju46 #AI #immunology
  • user avatar
    Our CEO @NoamSolomon1 shares his insight into immune cell profiling and its role in revealing cancer indicators in Kevin Mayer’s latest piece in @GENbio. #immunotherapy #singlecell #biotech genengnews.com/immunology/imm…
  • user avatar
    Hello! We’re Immunai and we’re excited to officially launch out of #stealth with $20M in seed funding today. Learn how we’re fully mapping the immune system to better detect, diagnose, and treat diseases from #COVID19 to #cancer in @crunchbasenews: tinyurl.com/yar2l96l
  • user avatar
    We're honored to be included on the list of America's Best Startup Employers of 2022, as ranked by @Forbes. Thank you to everyone at Immunai for making this company such an exciting and inspiring place to work, we wouldn't be here without each of you. forbes.com/lists/americas…
  • user avatar
    We’ve been recognized by @FastCompany as a World Changing Idea in the #AI and #Data category! We’re grateful for this validation in our technology, and look forward to many more milestones. View the full list here: tinyurl.com/rrw2b2sy #FCWorldChangingIdeas
  • user avatar
    Our single-cell tech expert, Eleni Mimitou, developed a new technique that makes it possible to simultaneously profile up to four modalities from each cell—which is necessary to better understand and treat disease. Read about in @10xGenomics' post:
  • user avatar
    Proud to enter a multi-year partnership with AstraZeneca to optimize clinical trials in oncology. Using our AI-powered platforms, we’re working together to bring new therapies to patients faster and more efficiently.
  • user avatar
    Today, @FastCompany recognized Immunai as one of the top 10 most innovative companies in artificial intelligence. We are honored to be included and grateful for our incredible team who has helped us to get to this point. fastcompany.com/90724347/most-… #FCMostInnovative #AI